New scan aims to clear up brain cancer confusion
NCT ID NCT06055790
Summary
This study is testing whether a special type of PET/CT scan using a tracer called 18F-fluciclovine can better identify and monitor brain metastases (cancer that has spread to the brain). Researchers want to see if this scan can more clearly show active cancer versus treatment side effects like scarring, which can be hard to tell apart on standard MRI scans. Up to 20 adults with known brain metastases will get the new scan before and after their standard treatment to see how it compares.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BRAIN METASTASES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Arizona Cancer Center at UMC North/University Medical Center
RECRUITINGTucson, Arizona, 85719, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.